Dopamine Hydrochloride Injection Shortage: Latest Availability and Manufacturer Updates
Areazine synthesizes this FDA drug-shortage notice directly from FDA's official public data feed. See our methodology for full source attribution and refresh cadence.
The FDA reports an ongoing shortage of Dopamine Hydrochloride Injection, a cardiovascular medication, though several presentations remain available from Baxter Healthcare.
What this FDA drug-shortage notice tells you, and what most readers miss
This notice was issued by FDA on April 6, 2026 and geographically references United States. Its severity classification of "medium" signals how the issuing agency weighs the risk of harm if no action is taken - "critical" and "high" tier alerts typically carry direct consumer actions, while "medium" and "low" tend toward informational guidance or monitoring advisories. The category it belongs to - Drug Shortages - determines the regulatory framework behind it, which shapes what mitigations (alternative therapies, allocation timelines, manufacturer guidance) are available and which agency holds oversight.
Most readers skim a notice like this, check whether they are personally affected, and move on. The more useful lens is to verify its scope, source, and timestamp, then compare related notices without assuming that one record proves a broader trend.
Areazine pairs this record with the original agency URL so you can check the primary source before acting. Its related labels are drug-shortage, fda, medication, Dopamine Hydrochloride.
What's in Shortage
Generic Name: Dopamine Hydrochloride Injection
Brand Name: DOPAMINE HYDROCHLORIDE AND DEXTROSE
Dosage Form: Injection
Therapeutic Category: Cardiovascular
Current Status: Current Shortage
Initial Posting Date: 11/06/2017
Last Updated: 02/02/2026
Dopamine Hydrochloride Injection is currently listed as being in shortage. This medication is primarily used within the cardiovascular therapeutic category.
Which Manufacturers Are Affected
According to the FDA database, the following manufacturer information is available:
Baxter Healthcare
- Status: Available
- Contact Info: 888-229-0001
- Available Presentations:
- Dopamine Hydrochloride In Dextrose 5% In Plastic Container, Injection, 80 mg/100 mL (NDC 0338-1005-03)
- Dopamine Hydrochloride In Dextrose 5% In Plastic Container, Injection, 160 mg/100 mL (NDC 0338-1007-02)
- Dopamine Hydrochloride In Dextrose 5% In Plastic Container, Injection, 80 mg/100 mL (NDC 0338-1005-02)
- Dopamine Hydrochloride In Dextrose 5% In Plastic Container, Injection, 160 mg/100 mL (NDC 0338-1007-03)
Why There's a Shortage
No specific reason for the shortage was provided in the source data at this time.
What Patients Should Do
If you are a patient or caregiver affected by this shortage, please take the following steps:
- Consult Your Healthcare Provider: Discuss your treatment plan and any concerns regarding medication availability with your doctor.
- Talk to Your Pharmacist: Pharmacists can provide the most current information regarding local stock and supply chain updates.
- Contact the Manufacturer: For specific questions regarding supply, you may contact Baxter Healthcare at 888-229-0001.
Disclaimer: This article is for informational purposes only and does not constitute medical advice. Patients should always consult with their healthcare provider or pharmacist regarding their medications and treatment options.
Source
Attribution: FDA Drug Shortage Database
Original source: FDA Official Notice ↗
Related Drug Shortages
All Drug Shortages →Frequently Asked Questions
Common questions about this FDA drug-shortage notice.